Edit. Perhaps I didn't understand. If Roche drops ITMN-191 entirely, and they license another PI from another company, they owe Intermune nothing? I read the 10k months ago but perhaps I misunderstood.
“I am a big believer in giving it all away and have always said that the best financial planning ends with bouncing the check to the undertaker.”